Prescott Group Capital Management’s Lyra Therapeutics LYRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-600	Closed	-$117K	–	180
2023 Q3	$117K	Buy	+600	New	+$117K	0.03%	157